Artwork

Content provided by BBC and BBC World Service. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BBC and BBC World Service or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

US drug companies and the NHS

18:03
 
Share
 

Manage episode 247743972 series 1301443
Content provided by BBC and BBC World Service. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BBC and BBC World Service or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Is Britain's health service really up for sale? Ahead of a general election in the UK, Ed Butler looks at why the NHS probably gets a good deal on drug prices compared with other countries, and why US drug companies might want the health service on the table in any post-Brexit trade deal between the US and the UK. We hear from the BBC's health editor Hugh Pym, US pharmaceutical industry analyst Nielsen Hobbs and Professor Allyson Pollock, director of the Institute of Health and Society at Newcastle University.

(Photo: Protestors show support for the NHS at a protest in London, Credit: Getty Images)

  continue reading

2044 episodes

Artwork

US drug companies and the NHS

Business Daily

8,216 subscribers

published

iconShare
 
Manage episode 247743972 series 1301443
Content provided by BBC and BBC World Service. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BBC and BBC World Service or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Is Britain's health service really up for sale? Ahead of a general election in the UK, Ed Butler looks at why the NHS probably gets a good deal on drug prices compared with other countries, and why US drug companies might want the health service on the table in any post-Brexit trade deal between the US and the UK. We hear from the BBC's health editor Hugh Pym, US pharmaceutical industry analyst Nielsen Hobbs and Professor Allyson Pollock, director of the Institute of Health and Society at Newcastle University.

(Photo: Protestors show support for the NHS at a protest in London, Credit: Getty Images)

  continue reading

2044 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide